MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway

BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer. The dismal outcome of ICC patients is due to lack of early diagnosis, the aggressive biological behavior of ICC and the lack of effective therapeutic options. Early diagnosis and prognosis of ICC by non...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jian-Hui, Zhu, Xiao-Xu, Li, Fu-Xi, Huang, Chen-Song, Huang, Xi-Tai, Wang, Jie-Qin, Gao, Zhuo-Xing, Li, Shi-Jin, Xu, Qiong-Cong, Zhao, Wei, Yin, Xiao-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882185/
https://www.ncbi.nlm.nih.gov/pubmed/31775892
http://dx.doi.org/10.1186/s13046-019-1477-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882185/
https://www.ncbi.nlm.nih.gov/pubmed/31775892
http://dx.doi.org/10.1186/s13046-019-1477-4

Ejemplares similares